- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Pain Management in Acute Gout: NSAIDs or COX-2 Inhibitors?
A recent meta-analysis assessed comparative clinical efficacy of NSAIDs and COX-2 inhibitors. Try these 7 questions on the findings - does your clinical experience match?
©htpix/stock.adobe.com
A 2020 meta-analysis published in BMJ Open assessed the comparative clinical efficacy of traditional non-selective NSAIDs and selective COX-2 inhibitors in patients with acute gout.
The main outcome measures included were mean change in pain Visual Analogue Scale score and 5-point Likert scale score on days 2–8. All of the following questions and answers are based on findings from this meta-analysis.
Do the analysis results match your experience in clinical practice?
Note: the meta-analysis did not include naproxen for comparisons, due to a lack of clinical trials. The analysis also did not include comparison to colchicine or corticosteroids.
1. Which of the following offers a clear advantage in terms of pain scores in acute gout?
A. Etoricoxib
B. Celecoxib
C. Meloxicam
D. Ibuprofen
